Cargando…
Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty
BACKGROUND: Although excellent clinical outcomes of supercapsular percutaneously assisted total hip arthroplasty (SuperPath) have been reported, the peri-operative blood loss has rarely been reported. The current study determined the blood loss during SuperPath and compared the blood loss with conve...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992970/ https://www.ncbi.nlm.nih.gov/pubmed/33766085 http://dx.doi.org/10.1186/s13018-021-02363-z |
_version_ | 1783669483297046528 |
---|---|
author | Hu, Yong Wang, Min-Cong Wang, Tao Meng, Yue Chao, Xiao-Min Zhu, Hui-Feng Li, Cheng-Guo Pan, Cheng-Long He, He-Bei |
author_facet | Hu, Yong Wang, Min-Cong Wang, Tao Meng, Yue Chao, Xiao-Min Zhu, Hui-Feng Li, Cheng-Guo Pan, Cheng-Long He, He-Bei |
author_sort | Hu, Yong |
collection | PubMed |
description | BACKGROUND: Although excellent clinical outcomes of supercapsular percutaneously assisted total hip arthroplasty (SuperPath) have been reported, the peri-operative blood loss has rarely been reported. The current study determined the blood loss during SuperPath and compared the blood loss with conventional posterolateral total hip arthroplasty (PLTH). METHODS: This retrospective study enrolled patients who underwent unilateral primary THA between January 2017 and December 2019. The demographic data, diagnoses, affected side, radiographic findings, hemoglobin concentration, hematocrit, operative time, transfusion requirements, and intra-operative blood loss were recorded. The peri-operative blood loss was calculated using the OSTHEO formula. Blood loss on the 1st, 3rd, and 5th post-operative days was calculated. Hidden blood loss (HBL) was determined by subtracting the intra-operative blood loss from the total blood loss. RESULTS: Two hundred sixty-three patients were included in the study, 85 of whom were in the SuperPath group and 178 in the posterolateral total hip arthroplasty (PLTH) group. Patient demographics, diagnoses, affected side, operative times, and pre-operative hemoglobin concentrations did not differ significantly between the two groups (all P > 0.05). Compared to the PLTH group, the SuperPath group had less blood loss, including intra-operative blood loss, 1st, 3rd, and 5th post-operative days blood loss, and HBL (all P < 0.05). Total blood loss and HBL was 790.07 ± 233.37 and 560.67 ± 195.54 mL for the SuperPath group, respectively, and 1141.26 ± 482.52 and 783.45 ± 379.24 mL for the PLTH group. PLTH led to a greater reduction in the post-operative hematocrit than SuperPath (P < 0.001). A much lower transfusion rate (P = 0.028) and transfusion volume (P = 0.019) was also noted in the SuperPath group. CONCLUSION: SuperPath resulted in less perioperative blood loss and a lower transfusion rate than conventional PLTH. |
format | Online Article Text |
id | pubmed-7992970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79929702021-03-25 Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty Hu, Yong Wang, Min-Cong Wang, Tao Meng, Yue Chao, Xiao-Min Zhu, Hui-Feng Li, Cheng-Guo Pan, Cheng-Long He, He-Bei J Orthop Surg Res Research Article BACKGROUND: Although excellent clinical outcomes of supercapsular percutaneously assisted total hip arthroplasty (SuperPath) have been reported, the peri-operative blood loss has rarely been reported. The current study determined the blood loss during SuperPath and compared the blood loss with conventional posterolateral total hip arthroplasty (PLTH). METHODS: This retrospective study enrolled patients who underwent unilateral primary THA between January 2017 and December 2019. The demographic data, diagnoses, affected side, radiographic findings, hemoglobin concentration, hematocrit, operative time, transfusion requirements, and intra-operative blood loss were recorded. The peri-operative blood loss was calculated using the OSTHEO formula. Blood loss on the 1st, 3rd, and 5th post-operative days was calculated. Hidden blood loss (HBL) was determined by subtracting the intra-operative blood loss from the total blood loss. RESULTS: Two hundred sixty-three patients were included in the study, 85 of whom were in the SuperPath group and 178 in the posterolateral total hip arthroplasty (PLTH) group. Patient demographics, diagnoses, affected side, operative times, and pre-operative hemoglobin concentrations did not differ significantly between the two groups (all P > 0.05). Compared to the PLTH group, the SuperPath group had less blood loss, including intra-operative blood loss, 1st, 3rd, and 5th post-operative days blood loss, and HBL (all P < 0.05). Total blood loss and HBL was 790.07 ± 233.37 and 560.67 ± 195.54 mL for the SuperPath group, respectively, and 1141.26 ± 482.52 and 783.45 ± 379.24 mL for the PLTH group. PLTH led to a greater reduction in the post-operative hematocrit than SuperPath (P < 0.001). A much lower transfusion rate (P = 0.028) and transfusion volume (P = 0.019) was also noted in the SuperPath group. CONCLUSION: SuperPath resulted in less perioperative blood loss and a lower transfusion rate than conventional PLTH. BioMed Central 2021-03-25 /pmc/articles/PMC7992970/ /pubmed/33766085 http://dx.doi.org/10.1186/s13018-021-02363-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Hu, Yong Wang, Min-Cong Wang, Tao Meng, Yue Chao, Xiao-Min Zhu, Hui-Feng Li, Cheng-Guo Pan, Cheng-Long He, He-Bei Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty |
title | Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty |
title_full | Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty |
title_fullStr | Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty |
title_full_unstemmed | Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty |
title_short | Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty |
title_sort | less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992970/ https://www.ncbi.nlm.nih.gov/pubmed/33766085 http://dx.doi.org/10.1186/s13018-021-02363-z |
work_keys_str_mv | AT huyong lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT wangmincong lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT wangtao lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT mengyue lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT chaoxiaomin lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT zhuhuifeng lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT lichengguo lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT panchenglong lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty AT hehebei lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty |